American FDA holds public discussion on LASIK and Phakic IOLs (PIOLs)
Representatives from the American Society of Cataract and Refractive Surgeon (ASCRS) made presentations yesterday in Fairfax, Virginia. The Food and Drug Administration (FDA) Ophthalmic Devices Panel (ODP) had committed to hold an open public discussion to allow people to make comments about LASIK and PIOLs. The presentations highlighted LASIK and its effect on quality of life, as well as restating the commitment of ASCRS to the upcoming LASIK Quality of Life Study. The military’s experience with LASIK was presented from members of the United States armed forces.
In preparation for today’s meeting, written and spoken testimony from both satisfied and dissatisfied LASIK patients had been sent to Karen F. Warburton of the Center for Devices and Radiological Health. Satisfied patients discussed improvements to their individual safety, ability to work effectively, enjoyment of social functions plus ability to drive.
Related posts:
- FDA recommends changes for eye laser patient labeling during public hearing Leading ophthalmologists plus LASIK patients at the Food and Drug...
- Long sight (hyperopia) correction appears stable up to 5 years after LASIK Update from the ASCRS in Chicago. LASIK for long sight...
- 9 out of 10 people choose blade free LASIK Since we introduced the Z-LASIK blade free LASIK laser...
- LASIK for USAF Pilots and Astronauts One week after surgery more than 76 percent of femtosecond...
- The BIG eye meeting - the ASCRS in Chicago 2008 The BIG eye surgeons meeting is coming up this week,...
Related posts brought to you by Yet Another Related Posts Plugin.
